Skip to product information
Tirzepatide 10mg
$61.00
| Specification | Details | |
|---|---|---|
| π§ͺ | Size | 10 mg Β· 3 mL |
| βοΈ | Form | Lyophilized powder |
| πΊπΈ | Manufactured | USA |
| 𧬠| Chemical Name | GIP/GLP-1 dual agonist analog (LY3298176) with γGlu-C20 diacid Lys20 modification |
| βοΈ | Molecular Formula | Cβββ HβββNββOββ |
| β | Purity | β₯98% (HPLC) β See Batch COA |
| π§ | Storage Conditions | Store at β20Β°C, desiccated, protected from light. Stable for up to 24 months in lyophilized form. |
| π― | Receptor Activity | Dual agonist of GIPR and GLP-1R in HEK293 cAMP assays; biased Ξ²-arrestin recruitment characterized in in vitro signaling-pathway studies. |
Β
Tirzepatide is an investigational dual agonist peptide that targets the GIP and GLP-1 receptors. In laboratory research, it has been studied for its effects on metabolic pathways involved in glucose regulation, insulin signaling, appetite, and body weight. This product is intended for laboratory research use only and is not approved for human or veterinary use.